Clinical Trials
6 trialsNCT02341495 2020-02-27
EXJADE
Loyola University
Phase 2 Terminated
NCT01159067 2019-06-18
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
City of Hope Medical Center
Phase 2 Terminated
NCT01273766 2018-09-07
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Wake Forest University Health Sciences
Phase 2 Completed
NCT03659084 2018-09-06
GREFFE
Hospices Civils de Lyon
Unknown
NCT00602446 2017-12-28
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT02413021 2016-02-25
The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens
Isfahan University of Medical Sciences
Phase 1 Unknown